ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3214

Impaired Phagocytosis of Apoptotic Cells in Pristane-Induced Lupus Simulates the Clearance Defect in Human SLE

Shuhong Han1, Haoyang Zuang1, Ravil Khaybullin2, Stepan Shumyak3, Anan Afaneh4, Xin Qi5, Lijun yang6 and Westley H. Reeves7, 1Division of Rheumatology and Clinical Immunology, University of Florida, Gainesville, FL, 2medicinal chemistry, University of Flordia, gainesville, FL, 3division of Rheumatology & Clinical Immunology, university of florida, gainesville, FL, 4Division of Rheumatology & Clinical Immunology, university of florida, gainesville, FL, 5medicinal chemistry, University of Florida, gainesville, FL, 6Pathology, Immunology & Laboratory Medicine, University of Florida, Gainesville, FL, 7Medicine, University of Florida, Gainesville, FL

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: apoptotic clearance, mouse model and phagocytosis, SLE

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Lupus Erythematosus - Animal Models

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Defective phagocytosis of dead cells is seen in SLE patients’ monocytes. Pristane-induced lupus causes accumulation of dead cells in tissues resembling that in SLE patients. However, the extent to which this reflects increased cell death vs. impaired removal of dead cells is unclear. The present studies addressed the clearance of dead cells in pristane-lupus

Methods: Clearance of dead cells from human bone marrow (BM) was examined by immunohistochemistry. The distribution of pristane in mouse tissues was detected by oil red staining and mass spectrometry. Murine macrophage (Mϕ) subsets were identified by flow cytometry (F4/80+CD11b+Ly6G–). Gene expression in sorted cells was determined by real-time PCR. Phagocytosis of pHrodo red-labeled thymocytes by Mϕ from pristane-treated (develop lupus) vs. mineral oil (MO)-treated (do not develop lupus) mice was assessed in vitro and in vivo by flow cytometry. Autophagy was quantified by Cyto-ID green staining.

Results:

Tissues from SLE patients and pristane-treated mice contained numerous dead cells (activated caspase-3+). In non-SLE patients undergoing BM ablation and massive cell death prior to stem cell transplantation, dead cells were found only within resident BM Mϕ, not free as in lupus BM, consistent with a high capacity to clear dead cells. After i.p. injection in mice, pristane was transported to the lung and BM and could be detected by oil red staining and mass spectrometry along with numerous dead cells. We hypothesized that exposure of Mϕ to pristane causes a phagocytosis defect that predisposes to lupus. Consistent with that model, resident Tim4+ peritoneal Mϕ disappeared within hours of either pristane or MO injection and were replaced by BM-derived neutrophils and Mϕ. Peritoneal Mϕ from pristane-treated mice were poorly phagocytic vs. those from MO-treated controls and cells from pristane-treated mice were deficient in the class A scavenger receptor Marco. Marco is known to mediate phagocytosis of apoptotic cells, and the Marco+ Mϕ subset from control mice efficiently took up dead cells. The uptake of dead cells by peritoneal Mϕ from MO-treated mice was inhibited by anti-Marco antibodies. Expression of Marco mRNA is regulated by the transcription factor Nrf2 and was low in pristane- vs. MO- treated mice. Autophagy, which has been found to regulate phagocytosis by modulating Nrf2-mediated Marco expression, was increased in pristane-treated mice.

Conclusion:

Pristane may cause lupus by inducing a phagocytosis defect. The mechanism appears to involve modulation of phagocytosis due to increased autophagy, resulting in decreased activation of Nrf2, decreased scavenger receptor expression, and impaired clearance of dead cells.


Disclosure: S. Han, None; H. Zuang, None; R. Khaybullin, None; S. Shumyak, None; A. Afaneh, None; X. Qi, None; L. yang, None; W. H. Reeves, None.

To cite this abstract in AMA style:

Han S, Zuang H, Khaybullin R, Shumyak S, Afaneh A, Qi X, yang L, Reeves WH. Impaired Phagocytosis of Apoptotic Cells in Pristane-Induced Lupus Simulates the Clearance Defect in Human SLE [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/impaired-phagocytosis-of-apoptotic-cells-in-pristane-induced-lupus-simulates-the-clearance-defect-in-human-sle/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impaired-phagocytosis-of-apoptotic-cells-in-pristane-induced-lupus-simulates-the-clearance-defect-in-human-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology